[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gamma Knife Devices Market, 2012-2023

January 2018 | 188 pages | ID: G4DABDBED75EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Gamma knife devices market: Gamma knife is one type of radiological surgery device which acts by focusing on low-dosage gamma radiation from various sources on accurate target. Gamma knife devices are used for treating metastatic brain tumours in brain from the sites like breast, lung, and skin, vascular malformations of brain, acoustic neuromas, meningioma’s tumors on the protective layers of the brain, trigeminal neuralgia causes severe facial pain and epilepsy of temporal lobe.

Global Market Outline: Gamma Knife Devices Market

Gamma knife devices market is propelling by the increase in demand of non-invasive procedures, rise in the prevalence of brain cancers, and rise in ageing of population globally. In addition, high success rate of gamma knife treatment, short recovery period, favorable health insurance policies, high government initiatives, growing awareness on radiation therapy are anticipated to boost the gamma knife devices market. However, stringent regulations for the approval of the radiation devices, high cost for gamma knife devices and lack of awareness in developing regions are expected to hinder the gamma knife devices market. Gamma knife device many alternative therapies namely cyber knife, linac radiosurgery, conventional brain surgery, proton therapy, and modified linear accelerators. Moreover, lack of skilled healthcare professionals to use the radiation devices and side effects of radiation therapy further hampering the growth of the gamma knife devices market.

Gamma knife devices market segmented based on application, anatomy, and end user

Based on application, gamma knife devices market is segmented into
  • Arteriovenous Malformations
  • Trigeminal Neuralgia
  • Cancer
  • Brain Metastases
  • Others
Based on anatomy, gamma knife devices market is segmented into
  • Head
  • Neck
  • Others
Based on end-user, gamma knife market is segmented into
  • Hospitals
  • Ambulatory Radiotherapy Centres
  • Cancer Research Institutes
  • Others
Gamma knife devices market expected to grow at significant CAGR rate during the forecast period. Market players are expanding their market presence by entering into new markets. For instance, in February 2017, Elekta’s received Medical Devices License from Health Canada for its Leksell Gamma Knife Icon radiosurgery system, the only stereotactic radio surgery SRS system designed specifically to target brain tissue. Product developments and new product launches are market strategies adopted by the market players.

Geographically Gamma knife devices market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be a major contributor for gamma knife devices market due to increased demand for radiological surgeries. In addition, favourable reimbursement policies and increase in awareness about radiation therapy are boosting the gamma knife devices market. Asia-Pacific region projecting lucrative opportunities for growth of gamma knife devices market owing to developing healthcare infrastructure, increase in awareness about radiotherapy surgeries and increase in prevalence of the neurological diseases. Adoption of cutting-edge technologies, rise in the medical tourism in emerging nation in Asia Pacific expected to fuel the market. Countries like China, Japan and India expected to be major markets in Asia Pacific Region. Latin America is offering lucrative opportunities for gamma knife devices market owing to increase in R&D investments in the manufacturing of radiosurgery equipment.

Some of the market players in gamma knife devices market are Elekta AB (Sweden), Varian Medical Systems, Inc. (U.S), Huiheng Medical, Inc. (China), Masep Infini Global, Inc. (U.S.), and Nordion, Inc. (Canada), to name a few

In June 2016, Japanse Ministry of Health, Labour and Welfare and the Nuclear regulation approved Elekta;s Leksell Gamma Knife for clinical use.
1. EXECUTIVE SUMMARY

2. GLOBAL GAMMA KNIFE DEVICES MARKET INTRODUCTION

2.1. Global Gamma Knife Devices Market – Taxonomy
2.2. Global Gamma Knife Devices Market –Definitions
  2.2.1. Application
  2.2.2. Anatomy
  2.2.3. End-User

3. GLOBAL GAMMA KNIFE DEVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Gamma Knife Devices Market Dynamics – Factors Impact Analysis
3.6. Global Gamma Knife Devices Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe
  3.6.3. Japan
3.7. Global Gamma Knife Devices Market – Application Pipeline Analysis

4. GLOBAL GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL GAMMA KNIFE DEVICES MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Arteriovenous Malformations
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Trigeminal Neuralgia
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Cancer
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Brain Metastases
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Others
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis

6. GLOBAL GAMMA KNIFE DEVICES MARKET FORECAST, BY ANATOMY, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Head
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Neck
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Others
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL GAMMA KNIFE DEVICES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Hospitals
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Ambulatory Radiotherapy Centres
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Cancer Research Institutes
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Others
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis

8. GLOBAL GAMMA KNIFE DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Region, 2017 – 2023

9. NORTH AMERICA GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Arteriovenous Malformations
  9.1.2. Trigeminal Neuralgia
  9.1.3. Cancer
  9.1.4. Brain Metastases
  9.1.5. Others
9.2. Anatomy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. Head
  9.2.2. Neck
  9.2.3. Others
9.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Hospitals
  9.3.2. Ambulatory Radiotherapy Centres
  9.3.3. Cancer Research Institutes
  9.3.4. Others
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Country, 2017 – 2023
9.6. North America Gamma Knife Devices Market Dynamics – Trends

10. EUROPE GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Arteriovenous Malformations
  10.1.2. Trigeminal Neuralgia
  10.1.3. Cancer
  10.1.4. Brain Metastases
  10.1.5. Others
10.2. Anatomy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. Head
  10.2.2. Neck
  10.2.3. Others
10.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Hospitals
  10.3.2. Ambulatory Radiotherapy Centres
  10.3.3. Cancer Research Institutes
  10.3.4. Others
10.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Hospital Pharmacies
  10.4.2. Retail Pharmacies
  10.4.3. Online Pharmacies
  10.4.4. Drug Stores
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.5.1. Germany
  10.5.2. UK
  10.5.3. France
  10.5.4. Spain
  10.5.5. Italy
  10.5.6. Russia
  10.5.7. Poland
  10.5.8. Rest of Europe
10.6. Europe Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Country, 2017 – 2023
10.7. Europe Gamma Knife Devices Market Dynamics – Trends

11. ASIA-PACIFIC GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Arteriovenous Malformations
  11.1.2. Trigeminal Neuralgia
  11.1.3. Cancer
  11.1.4. Brain Metastases
  11.1.5. Others
11.2. Anatomy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. Head
  11.2.2. Neck
  11.2.3. Others
11.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Hospitals
  11.3.2. Ambulatory Radiotherapy Centres
  11.3.3. Cancer Research Institutes
  11.3.4. Others
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Country, 2017 – 2023
11.6. Asia-Pacific Gamma Knife Devices Market Dynamics – Trends

12. LATIN AMERICA GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Arteriovenous Malformations
  12.1.2. Trigeminal Neuralgia
  12.1.3. Cancer
  12.1.4. Brain Metastases
  12.1.5. Others
12.2. Anatomy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. Head
  12.2.2. Neck
  12.2.3. Others
12.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Hospitals
  12.3.2. Ambulatory Radiotherapy Centres
  12.3.3. Cancer Research Institutes
  12.3.4. Others
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
12.5. Latin America Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Country, 2017 – 2023
12.6. Latin America Gamma Knife Devices Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA GAMMA KNIFE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Arteriovenous Malformations
  13.1.2. Trigeminal Neuralgia
  13.1.3. Cancer
  13.1.4. Brain Metastases
  13.1.5. Others
13.2. Anatomy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. Head
  13.2.2. Neck
  13.2.3. Others
13.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Hospitals
  13.3.2. Ambulatory Radiotherapy Centres
  13.3.3. Cancer Research Institutes
  13.3.4. Others
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.4.1. Gulf Cooperation Council (GCC) Countries
  13.4.2. Israel
  13.4.3. South Africa
  13.4.4. Rest of MEA
13.5. MEA Gamma Knife Devices Market - Opportunity Analysis Index, By Application, By Anatomy, By End-User, and Country, 2017 – 2023
13.6. MEA Gamma Knife Devices Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Elekta AB (Sweden)
  14.2.2. Varian Medical Systems, Inc. (U.S)
  14.2.3. Huiheng Medical, Inc. (China)
  14.2.4. Masep Infini Global, Inc. (U.S.)
  14.2.5. Nordion, Inc. (Canada)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications